DIALYSIS · CCN 212739

DaVita Greenmount Central Dialysis

Baltimore, MD 21202

DialysisProfitDaVita
$3.4M
TOTAL REVENUE
-4.3%
OPERATING MARGIN
1 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.4M
Total costs
$3.5M
Operating income (rev − costs)
−$144K
Operating margin
-4.3%
Total charges
$3.5M
Total treatments
9,998
Dialysis stations
20

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.4477—
Fistula Rate
DFC_FISTULA_RATE
44.187—
Five Star Rating
DFC_FIVE_STAR
1——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.2251—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
115.162—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.39——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2987—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
16.6209—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
5.487—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
32.161—
Standardized ED Visits Ratio
DFC_SEDR
1.1437—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
34.131—